Immunostimulatory activity of haptenated proteins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 12, 2009, Pages 4782-4787

  Palm, Noah W ^a   Medzhitov, Ruslan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Antibody; Innate immunity; Toll like receptor

Indexed keywords

ADJUVANT; ANTIGEN; HAPTENATED PROTEIN; PROTEIN DERIVATIVE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; ALUMINUM HYDROXIDE; FREUND ADJUVANT; HAPTEN; IMMUNOGLOBULIN G; MYELOID DIFFERENTIATION FACTOR 88; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; C57BL 6 MOUSE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; IMMUNITY; IMMUNIZATION; IMMUNOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALUMINUM HYDROXIDE; ANIMALS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; FREUND'S ADJUVANT; HAPTENS; IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 63849233160     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0809403105     Document Type: Article

References (46)

1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801.
2. Brown GD, Gordon S (2001) Immune recognition. A new receptor for beta-glucans. Nature 413:36-37.
3. LeibundGut-Landmann S, et al. (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630-638.
4. Acosta-Rodriguez EV, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memorycells. Nat Immunol 8:639-646.
5. Kanneganti TD, Lamkanfi M, Nunez G (2007) Intracellular NOD-like receptors in host defense and disease. Immunity 27:549-559.
6. Kato H, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
7. Koyama S, et al. (2007) Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 179:4711-4720.
8. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995.
9. Pasare C, Medzhitov R (2004) Toll-dependent control mechanisms of CD4 T cell activation. Immunity21:733-741.
10. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438:364-368.
11. Schnare M, et al. (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2:947-950.
12. Ruprecht CR, Lanzavecchia A (2006) Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 36:810-816.
13. Heer AK, et al. (2007) TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol 178:2182-2191.
14. Guay HM, Andreyeva TA, Garcea RL, Welsh RM, Szomolanyi-Tsuda E (2007) MyD88 is required for the formation of long-term humoral immunity to virus infection. J Immunol 178:5124-5131.
15. Jegerlehner A, et al. (2007) TLR9 signaling in B cells determines class switch recombination to IgG2a. J Immunol 178:2415-2420.
16. Groom JR, et al. (2007) BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 204:1959-1971.
17. Leadbetter EA, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607.
18. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823-835.
19. Gavin AL, et al. (2006) Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314:1936-1938.
20. Nemazee D, Gavin A, Hoebe K, Beutler B (2006) Immunology: Toll-like receptors and antibody responses. Nature 441:E4; discussion E4.
21. Meyer-Bahlburg AKS, Rawlings DJ (2007) B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med.
22. Mitchison NA (1971) The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis. Eur J Immunol 1:10-17.
23. Adachi O,et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9:143-150.
24. + T cell-mediated suppression by dendritic cells. Science 299:1033-1036.
25. Shimizu T, et al. (2007) T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies. Int Immunol 19:1157-1164.
26. Landsteiner K (1962) The Specificity of Serological Reactions (Harvard Univ Press, Cambridge, MA) 3rd Ed.
27. Lanzavecchia A, Sallusto F (2007) Toll-like receptors and innate immunity in B-cell activation and antibody responses. CurrOpin Immunol 19:268-274.
28. Billiau A, Matthys P (2001) Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 70:849-860.
29. Neuberger A, Tatum EL (1972) Immunogenicity (North Holland Publishing Company, London) p 584.
30. + T cell response. Immunity25:655-664.
31. Kobayashi KS, et al. (2005) Nod2-dependentregulation ofinnate and adaptive immunityin the intestinal tract. Science 307:731-734.
32. + T cell priming during respiratory fungal infection. Immunity 25:665-675.
33. Martin S, Weltzien HU (1994) T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol 104:10-16.
34. Shornick LP, et al. (1996) Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 183:1427-1436.
35. Martinon F, Tschopp J (2004) Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561-574.
36. Sutterwala FS, et al. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317-327.
37. Watanabe H, et al. (2007) Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 127:1956-1963.
38. Eisenbarth SC,ColegioOR,O'ConnorW,SutterwalaFS,Flavell RA(2008)Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122-1126.
39. Franchi L, Nunez G (2008) The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol 38:2085-2089.
40. Li H, Nookala S, Re F (2007) Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol 178:5271-5276.
41. Li H, Willingham SB, Ting JP, Re F (2008) Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated byNLRP3. J Immunol 181:17-21.
42. Willingham SB, et al. (2007) Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe 2:147-159.
43. Taxman DJ, et al. (2006) Cutting edge: ASC mediates the induction of multiple cytokines by Porphyromonas gingivalis via caspase-1-dependent and -independent pathways. J Immunol 177:4252-4256.
44. Fritz JH, et al. (2007) Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26:445-459.
45. Herold K, et al. (2007) Receptor for advanced glycation end products (RAGE) in a dash to the rescue: Inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 82:204-212.
46. Liliensiek B, et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113:1641-1650.